
The President of the Republic Sergio Mattarella, speaking at the "Research Days" at the Quirinale, criticized the prejudicial opposition to vaccines, defining it as a disconcerting symptom in the face of the tragic avoidable consequences.
AI-generated summary
President Mattarella expressed his position during the "Research Days" event held at the Quirinale.
"Prejudicial opposition to vaccines is one of the most disconcerting symptoms: when we find ourselves faced with painful news events, with adults or children risking or even losing their lives which they could have easily defended, we feel the need to counter the work of those who try to poison opinion". The President of the Republic, Sergio Mattarella, says this, speaking at the "Research Days", at the Quirinale.
(article being updated)

Ten people, including seven minors, were poisoned by carbon monoxide in two separate incidents in Follina and Loria, in the province of Treviso, due to the use of domestic braziers.

The President of the Republic Sergio Mattarella condemned the spread of fake news on vaccines during the celebration of "Research Days", defining the prejudicial opposition to vaccination as a disconcerting and dangerous phenomenon.

Michele Reni, oncologist at San Raffaele and winner of the Airc award, discusses the prospects of oncological research. While there is still no definitive cure, the medical goal remains to improve treatments to extend patient survival.

President Sergio Mattarella, during the celebration of 'The Days of Research' at the Quirinale, exalted the value of global scientific cooperation, while denouncing misinformation, social stigma and inequalities in access to health.

President Sergio Mattarella, during the celebration of "I Giorni della Ricerca" at the Quirinale, underlined the importance of global collaboration in science, warning against the geopolitical barriers that hinder health prevention.

The INTerpath-001 study demonstrated that a personalized mRNA vaccine, combined with pembrolizumab, significantly reduces the risk of recurrence and metastasis in high-risk melanoma, offering a new post-operative therapeutic frontier.